Medicare Chemotherapy Bill Needed To Ensure Reimbursement Covers Cost, ASCO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
American Society of Clinical Oncology interim measure would ensure oncologists’ Medicare Part B reimbursement for drugs cover acquisition costs. ASCO is collecting data to quantify losses to physicians due to payment changes made through Medicare Rx law.